This is an in vitro rapid, simultaneous qualitative detection and differentiation of nucleocapsid antigen from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Influenza type A virus, Influenza type B virus, Respiratory Syncytial Virus (RSV) and Adenovirus (ADV) directly from anterior nasal swab specimens obtained from individuals, who are suspected of respiratory viral infection.